Evidence map›Paper›PMID 34811805›Full record

ArticleJournal of clinical laboratory analysis2022

Significance of preoperative blood tests in the prognosis of colorectal cancer: A prospective, multicenter study from Hungary.

Adrienn Biró, Péter Kolozsi, Attila Nagy, Zsolt Varga, Zsolt Káposztás, Dezső Tóth

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Journal of clinical laboratory analysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Adrienn BiróDepartment of Surgery, Moritz Kaposi General Hospital, Kaposvár, Hungary.ORCID https://orcid.org/0000-0003-1002-6098
Péter KolozsiDepartment of General Surgery, University of Debrecen, Kenézy Gyula Teaching Hospital, Debrecen, Hungary.ORCID https://orcid.org/0000-0003-1980-5434
Attila NagyFaculty of Public Health, University of Debrecen, Debrecen, Hungary.ORCID https://orcid.org/0000-0002-0554-7350
Zsolt VargaDepartment of General Surgery, University of Debrecen, Kenézy Gyula Teaching Hospital, Debrecen, Hungary.ORCID https://orcid.org/0000-0002-7516-3619
Zsolt KáposztásDepartment of Surgery, Moritz Kaposi General Hospital, Kaposvár, Hungary.ORCID https://orcid.org/0000-0001-9281-0550
Dezső TóthDepartment of Surgery, Borsod-Abaúj-Zemplén County Hospital and University Teaching Hospital, Miskolc, Hungary.ORCID https://orcid.org/0000-0001-7301-2705
University of Debrecen · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe focus of this study was to analyze the prognostic value of different combinations of inflammatory and coagulation factors using preoperative blood and to appraise the clinical importance of these biomarkers in colorectal cancer patients.

methodsA prospective, multicenter study included patients undergoing radical colorectal surgery in three county hospitals. Inflammatory and coagulation markers were analyzed preoperatively.

resultsTwo hundred and one patients were included. We examined patients based on their tumor localization. Colon cancer group involved patients with the tumor localized in the colon (n = 105, 52.24%) and rectal cancer group the patients with the tumor in the rectum (n = 96, 47.76%). Examining coagulation factors, univariate Cox analysis of colon cancer patients showed that activated partial thromboplastin time (p = 0.020) was significantly associated with overall survival, but we could not prove it in multivariate analysis. In colon cancer patients, neutrophil-to-lymphocyte ratio (NLR, p < 0.001) was positively correlated with tumor size and had significant association (χ

conclusionNLR was proved to be an independent prognostic factor for DFS in patients with non-metastatic colon cancer. NLR might help to recognize the high-risk patients between patients with the same tumor-node-metastasis stage and could help with the decision on adjuvant chemotherapy. Since the biomarkers in preoperative blood tests are habitually evaluated, NLR could be an inexpensive prognostic marker that can be easily assessed in clinical practice.

Indexed as

Colorectal NeoplasmsAdultAgedAged, 80 and overBiomarkersDisease-Free SurvivalFemaleHematologic TestsHumansHungaryMaleMiddle AgedMultivariate AnalysisPrognosisProspective StudiesBiomarkersbiomarkercolorectal cancerlaboratoryleukocyteneutrophilprognosticsurvival

Identifiers

PMID34811805
PMCPMC8761412
OpenAlexW3215040937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.